Authorization is the first and foundational phase of the work. It takes approximately thirty days. It answers one question: what is this business, actually? The question is not rhetorical. The phase produces three deliverables, each one feeding the next—the artifacts every subsequent phase draws from.
The Persuasion Genome
The Authorization article treats this deliverable in full. In short: the expert, their senior operators, and their existing clients are interviewed in a specific sequence designed to surface the facts that constitute the firm's commercial reality. The interviews are not focus groups and are not brand workshops. They are structured elicitations whose purpose is to produce an inventory of true, verifiable statements about what the firm does, how it does it, why clients choose it, which outcomes it reliably produces, and which mechanisms distinguish its operation from the market's category defaults. The inventory, structured and reconciled against the business's operational reality and tested for coherence, becomes the Persuasion Genome—the firm's revealed essence rendered into a canonical reference document in the firm's own language. The constitution of the business, as it is sometimes called: everything downstream must be in alignment with it, and nothing downstream can contradict it.
The Genome is tested, as it is produced, against four dimensions. Competence—can the business reliably get the client the result. Depth—the systematized mechanism by which that result is produced. Delivery—the quality of the client's experience inside the service; the attention and responsiveness they receive; the degree to which the business acts like it values the client's money as well as the client's result. Perceived value—whether the pricing the business commands reads to the market as proportionate to the risk the business is diffusing on the client's behalf. The four are held jointly. If any one registers as weak, the Genome surfaces the weakness and the standing recommendation is to pause and address the gap before any further work is done. The method is unbiased by construction, and the expert's own voice—authored into the Genome's content through the interviews—is the voice the pause recommendation is made in.
Paired with the Genome in the broader method is the Atomic Creative Index, built as a direct extension of the Genome's substantive work. Where the Genome holds the firm's constitutive facts, the Index renders those facts into a bounded, truth-governed inventory of persuasive units from which every subsequent ad, page, and message is composed. The Index is the commercial expression of the Genome, and it is treated in full in its own article.
The Market Analysis
A separate movement runs alongside the Genome's production. Where the Genome examines the business, the market analysis examines the market: the sophistication stage of the audience (how many adjacent offers has this audience seen, and what has it learned from them); the competitive density on each candidate surface (who else is spending here, with what claim, at what frequency); the white space available for a distinct position; the mechanical constraints of the surfaces themselves (which audience targeting is available, which creative formats perform, which special-category rules apply). The market analysis is a wholesale examination of the ground the business is about to deploy to. Its purpose is to determine what the market itself requires of a serious contender in this specific vertical, at this specific sophistication stage, on these specific surfaces.
The marketability check runs inside this movement. It asks a binary operational question: does the firm's ideal client exist, in scalable volume, on the surfaces the Blueprint would deploy to. If the answer is yes, the Blueprint proceeds to design against those surfaces. If the answer surfaces structural reasons the ICP cannot be reached at the scale the business needs, the finding is reported honestly, and the Blueprint names the structural constraint rather than papering over it. The marketability check carries the method's authority precisely because it can produce a verdict the expert will not want to hear.
The Strategic Blueprint
The Genome's substantive content and the market analysis's conclusions converge into the Strategic Blueprint—the capstone deliverable of Authorization and the map Construction builds against, item by item. The Blueprint is a plan, written down, that specifies in operational detail what the next phase will build: the surfaces the machine will deploy to and the order they come online, the offers the business will lead with and the sequencing of offers across the funnel, the audience the ad accounts will serve, the geographic targeting and the daypart structure, the budget pacing, the measurement regime, the sophistication-appropriate tone the creative will carry. The Blueprint is firm-specific by construction, and that is why it has no deep-dive article of its own: there is no generic answer honest enough to publish.
The Blueprint carries a signature at the bottom: the Proof Standard. The Standard is a document the practitioner signs. It specifies, in operational language, what the machine will produce when complete and the criteria by which its performance will be adjudicated. For a business with a short sales cycle, the Standard specifies revenue thresholds and the attribution model those thresholds will be measured against. For a business with a long enterprise cycle, the Standard specifies qualified-opportunity volume, cost per qualified opportunity, pipeline economics, and the defensible projection of what scaling will produce. The Standard is a pledge—a signed commitment, before anything downstream is built, that the machine the practitioner is about to construct will clear the Standard, or the practitioner will keep working, on their own time, out of their own pocket if the correction requires it, until it does. The client does not sign a target. The practitioner signs one. The client's role, from the moment the Blueprint is accepted, is to hold the practitioner to what has been put in writing.
The Standard matters because it reclassifies the work from a hope into an adjudicable commitment. The expert knows, before Construction begins, exactly what the machine is being built to produce and what the practitioner is personally on the hook for. The remaining phases run against a document both parties can read in the morning.
By the end of Authorization, the business has: a Genome capturing its revealed essence, with the Index paired as its commercial expression; a market analysis mapping the ground the business is about to enter; and a signed Strategic Blueprint, carrying the Proof Standard, specifying exactly what the machine will do and what the practitioner has committed to. The business now has, for the first time, an operational answer to the question of what it actually is—and an adjudicable commitment, in writing, from the person about to build its online acquisition machine. The next phase takes the Blueprint and builds the machine itself.